Skip to content

Effect of Beetroot Juice on Reducing Hypertension in Autosomal Dominant Polycystic Kidney Disease

Double-Blind, Randomised Placebo-Controlled Study to Determine the Effect of Beetroot Juice on Reducing Blood Pressure in Hypertensive Adults With Autosomal Dominant Polycystic Kidney Disease

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05401409
Acronym
BEET-PKD
Enrollment
60
Registered
2022-06-02
Start date
2022-05-05
Completion date
2023-03-24
Last updated
2025-06-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Autosomal Dominant Polycystic Kidney, Hypertension, Endothelial Dysfunction

Keywords

Autosomal Dominant Polycystic Kidney Disease, ADPKD, Beetroot juice, Hypertension, Nitrate supplementation, Nitric oxide

Brief summary

People with autosomal dominant polycystic kidney disease (ADPKD) develop high blood pressure and kidney disease. Previous studies have shown that a commonly occurring chemical, nitric oxide (NO), is reduced in ADPKD, and may contribute, in part, to high blood pressure in this condition. Nitrate is found in high concentrations naturally in beetroots, and increases NO. The aim of this study is to determine if beetroot juice reduces blood pressure in hypertensive people with ADPKD.

Interventions

DIETARY_SUPPLEMENTBeetroot juice

70mls beetroot juice (400mg nitrate) given daily for 4 weeks

70mls beetroot juice (nitrate-depleted) given daily for 4 weeks

Sponsors

Westmead Institute for Medical Research
CollaboratorUNKNOWN
Western Sydney Local Health District
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
QUADRUPLE (Subject, Caregiver, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Diagnosis of Autosomal Dominant Polycystic Kidney Disease * Age \> 18 years old * Estimated Glomerular Filtration Rate (eGFR) \> 30 mL/min/1.73m2 * Treatment with at least one anti-hypertensive

Exclusion criteria

* Inability to provide Informed Consent * Labile, unstable, uncontrolled hypertension and/or changes in BP treatment 28 days prior to the screening visit * Non-compliance with study procedures and/or daily BP measurements during the screening period * Medical conditions or treatments that might interfere with the generation of NO metabolites or the primary endpoint (e.g. nitrate drugs; cigarette smoking; unwilling to stop using antiseptic mouthwash; severe, uncontrolled hypercholesterolemia; pregnancy or post-partum and lactating) * Any serious or other medical conditions that might interfere with follow-up or stability of blood pressure (e.g. current active malignancies; uncontrolled diabetes mellitus with elevated HbA1c \> 10%) * Dislike of taste of beetroot juice * Allergy to beetroot * Enrolled in other clinical trials

Design outcomes

Primary

MeasureTime frameDescription
Change in Clinic Systolic and Diastolic Blood Pressure From Baseline to 4 Weeks (End of Study)4 weeksChange in systolic and diastolic blood pressure over two time points - from readings taken at baseline (visit 1) compared with readings taken at 4 weeks (which was the end of the study; visit 3)

Secondary

MeasureTime frameDescription
Average Change in Daily Home Systolic and Diastolic Blood Pressure Per Week, Over 4 Weeks4 weeksReported change in blood pressure is average change per week, over 4 weeks
Urinary Albumin to Creatinine Ratio at Baseline and at 4 Weeks (End of Study)4 weeks
Change in Serum Nitric Oxide Metabolite Levels From Baseline to 4 Weeks (End of the Study)4 weeks
Change in Salivary Nitric Oxide Metabolite Levels From Baseline to 4 Weeks (End of the Study)4 weeks
Serum Asymmetric Dimethylarginine at Baseline and at 4 Weeks (End of the Study)4 weeksAsymmetric dimethylarginine (ADMA) which is a recognized marker of endothelial dysfunction and inhibitor of nitric oxide

Countries

Australia

Participant flow

Participants by arm

ArmCount
Nitrate-rich Beetroot Juice
Beetroot juice containing naturally occurring nitrate (400mg total nitrate) Beetroot juice: 70mls beetroot juice (400mg nitrate) given daily for 4 weeks
30
Nitrate-depleted Beetroot Juice
Beetroot juice with nitrate removed Nitrate-depleted beetroot juice: 70mls beetroot juice (nitrate-depleted) given daily for 4 weeks
30
Total60

Withdrawals & dropouts

PeriodReasonFG000FG001
Overall StudyLost to Follow-up10

Baseline characteristics

CharacteristicNitrate-rich Beetroot JuiceNitrate-depleted Beetroot JuiceTotal
Age at diagnosis30.9 years
STANDARD_DEVIATION 13.31
33.1 years
STANDARD_DEVIATION 13.1
32 years
STANDARD_DEVIATION 13.2
Age, Continuous49.5 years
STANDARD_DEVIATION 13.5
49.3 years
STANDARD_DEVIATION 12.46
49.4 years
STANDARD_DEVIATION 13
Diagnosis confirmatory test (radiographic)30 Participants30 Participants60 Participants
Employment status, categorical (Part time, Full time))
Full time
22 Participants26 Participants48 Participants
Employment status, categorical (Part time, Full time))
Part time
7 Participants4 Participants11 Participants
Employment status, categorical (Part time, Full time))
Umemployed
1 Participants0 Participants1 Participants
Factor precipitating diagnosis, categorical (family history screening; pain; hypertension;incidental
Hypertension
8 Participants2 Participants10 Participants
Factor precipitating diagnosis, categorical (family history screening; pain; hypertension;incidental
Incidental
2 Participants5 Participants7 Participants
Factor precipitating diagnosis, categorical (family history screening; pain; hypertension;incidental
Other
5 Participants4 Participants9 Participants
Factor precipitating diagnosis, categorical (family history screening; pain; hypertension;incidental
Pain
3 Participants6 Participants9 Participants
Factor precipitating diagnosis, categorical (family history screening; pain; hypertension;incidental
Screening (family history)
12 Participants13 Participants25 Participants
Family history of ADPKD
No
8 Participants4 Participants12 Participants
Family history of ADPKD
Unknown
0 Participants3 Participants3 Participants
Family history of ADPKD
Yes
22 Participants23 Participants45 Participants
Race/Ethnicity, Customized
Asian
8 Participants7 Participants15 Participants
Race/Ethnicity, Customized
Caucasian
20 Participants22 Participants42 Participants
Race/Ethnicity, Customized
Other
2 Participants1 Participants3 Participants
Sex: Female, Male
Female
13 Participants14 Participants27 Participants
Sex: Female, Male
Male
17 Participants16 Participants33 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
0 / 290 / 30
other
Total, other adverse events
18 / 2911 / 30
serious
Total, serious adverse events
0 / 290 / 30

Outcome results

Primary

Change in Clinic Systolic and Diastolic Blood Pressure From Baseline to 4 Weeks (End of Study)

Change in systolic and diastolic blood pressure over two time points - from readings taken at baseline (visit 1) compared with readings taken at 4 weeks (which was the end of the study; visit 3)

Time frame: 4 weeks

Population: One patient in the nitrate-rich group was lost to follow-up.

ArmMeasureGroupValue (MEAN)Dispersion
Nitrate-rich Beetroot JuiceChange in Clinic Systolic and Diastolic Blood Pressure From Baseline to 4 Weeks (End of Study)Systolic blood pressure-5.36 mmHgStandard Deviation 12.69
Nitrate-rich Beetroot JuiceChange in Clinic Systolic and Diastolic Blood Pressure From Baseline to 4 Weeks (End of Study)Diastolic blood pressure-3.55 mmHgStandard Deviation 7.08
Nitrate-depleted Beetroot JuiceChange in Clinic Systolic and Diastolic Blood Pressure From Baseline to 4 Weeks (End of Study)Systolic blood pressure-7.65 mmHgStandard Deviation 14.07
Nitrate-depleted Beetroot JuiceChange in Clinic Systolic and Diastolic Blood Pressure From Baseline to 4 Weeks (End of Study)Diastolic blood pressure-2.73 mmHgStandard Deviation 7.81
Secondary

Average Change in Daily Home Systolic and Diastolic Blood Pressure Per Week, Over 4 Weeks

Reported change in blood pressure is average change per week, over 4 weeks

Time frame: 4 weeks

ArmMeasureGroupValue (MEAN)
Nitrate-rich Beetroot JuiceAverage Change in Daily Home Systolic and Diastolic Blood Pressure Per Week, Over 4 WeeksSystolic blood pressure-0.51 mmHg/week
Nitrate-rich Beetroot JuiceAverage Change in Daily Home Systolic and Diastolic Blood Pressure Per Week, Over 4 WeeksDiastolic blood pressure-0.24 mmHg/week
Nitrate-depleted Beetroot JuiceAverage Change in Daily Home Systolic and Diastolic Blood Pressure Per Week, Over 4 WeeksSystolic blood pressure-0.55 mmHg/week
Nitrate-depleted Beetroot JuiceAverage Change in Daily Home Systolic and Diastolic Blood Pressure Per Week, Over 4 WeeksDiastolic blood pressure-0.47 mmHg/week
Secondary

Change in Salivary Nitric Oxide Metabolite Levels From Baseline to 4 Weeks (End of the Study)

Time frame: 4 weeks

Secondary

Change in Serum Nitric Oxide Metabolite Levels From Baseline to 4 Weeks (End of the Study)

Time frame: 4 weeks

ArmMeasureValue (MEDIAN)
Nitrate-rich Beetroot JuiceChange in Serum Nitric Oxide Metabolite Levels From Baseline to 4 Weeks (End of the Study)20.08 µM
Nitrate-depleted Beetroot JuiceChange in Serum Nitric Oxide Metabolite Levels From Baseline to 4 Weeks (End of the Study)0.97 µM
Secondary

Serum Asymmetric Dimethylarginine at Baseline and at 4 Weeks (End of the Study)

Asymmetric dimethylarginine (ADMA) which is a recognized marker of endothelial dysfunction and inhibitor of nitric oxide

Time frame: 4 weeks

ArmMeasureGroupValue (MEDIAN)Dispersion
Nitrate-rich Beetroot JuiceSerum Asymmetric Dimethylarginine at Baseline and at 4 Weeks (End of the Study)Baseline ADMA level0.47 umol/LStandard Deviation 0.08
Nitrate-rich Beetroot JuiceSerum Asymmetric Dimethylarginine at Baseline and at 4 Weeks (End of the Study)4 week ADMA level (end of study)0.50 umol/LStandard Deviation 0.1
Nitrate-depleted Beetroot JuiceSerum Asymmetric Dimethylarginine at Baseline and at 4 Weeks (End of the Study)Baseline ADMA level0.47 umol/LStandard Deviation 0.09
Nitrate-depleted Beetroot JuiceSerum Asymmetric Dimethylarginine at Baseline and at 4 Weeks (End of the Study)4 week ADMA level (end of study)0.52 umol/LStandard Deviation 0.11
Secondary

Urinary Albumin to Creatinine Ratio at Baseline and at 4 Weeks (End of Study)

Time frame: 4 weeks

ArmMeasureGroupValue (MEDIAN)
Nitrate-rich Beetroot JuiceUrinary Albumin to Creatinine Ratio at Baseline and at 4 Weeks (End of Study)Baseline2.2 mg/mmol
Nitrate-rich Beetroot JuiceUrinary Albumin to Creatinine Ratio at Baseline and at 4 Weeks (End of Study)4 weeks (end of study)2.5 mg/mmol
Nitrate-depleted Beetroot JuiceUrinary Albumin to Creatinine Ratio at Baseline and at 4 Weeks (End of Study)Baseline3.9 mg/mmol
Nitrate-depleted Beetroot JuiceUrinary Albumin to Creatinine Ratio at Baseline and at 4 Weeks (End of Study)4 weeks (end of study)3.6 mg/mmol

Source: ClinicalTrials.gov · Data processed: Feb 10, 2026